Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(2.22)
# 2,741
Out of 4,915 analysts
383
Total ratings
37.24%
Success rate
-1.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Maintains: Buy | $10 → $15 | $4.15 | +261.45% | 20 | Jul 30, 2025 | |
| CMPS COMPASS Pathways | Reiterates: Buy | $45 | $4.43 | +915.80% | 16 | Jul 15, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.63 | +230.58% | 18 | Jun 27, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $3.07 | +225.73% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $0.74 | +577.32% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.55 | +1,726.82% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.12 | +1,126.49% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.35 | +199.90% | 21 | Jun 2, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $13.92 | +402.87% | 15 | May 29, 2025 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $1.01 | +397.51% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $4.68 | +1,182.05% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $15.88 | +403.78% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $14.07 | +184.29% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.97 | +910.10% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $34.45 | +103.19% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $18.79 | +325.76% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $396.92 | +25.97% | 26 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.44 | +594.44% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.00 | +401.25% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $8.77 | +527.14% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.03 | +2,086.88% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $32.84 | +158.83% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $7.59 | +1,876.28% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $11.00 | +518.46% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $248.77 | +36.67% | 1 | Aug 18, 2021 |
Atai Life Sciences
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $4.15
Upside: +261.45%
COMPASS Pathways
Jul 15, 2025
Reiterates: Buy
Price Target: $45
Current: $4.43
Upside: +915.80%
Altimmune
Jun 27, 2025
Reiterates: Buy
Price Target: $12
Current: $3.63
Upside: +230.58%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $3.07
Upside: +225.73%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $0.74
Upside: +577.32%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.55
Upside: +1,726.82%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.12
Upside: +1,126.49%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $33.35
Upside: +199.90%
uniQure
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $13.92
Upside: +402.87%
Oncolytics Biotech
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.01
Upside: +397.51%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.68
Upside: +1,182.05%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $15.88
Upside: +403.78%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $14.07
Upside: +184.29%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $2.97
Upside: +910.10%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $34.45
Upside: +103.19%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $18.79
Upside: +325.76%
Apr 2, 2025
Reiterates: Buy
Price Target: $500
Current: $396.92
Upside: +25.97%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.44
Upside: +594.44%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $2.00
Upside: +401.25%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $8.77
Upside: +527.14%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.03
Upside: +2,086.88%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $32.84
Upside: +158.83%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $7.59
Upside: +1,876.28%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $11.00
Upside: +518.46%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $248.77
Upside: +36.67%